Mentions
Extended reach
Total likes
Video views
AI synopsis
The overall sentiment reflects interest and agreement, exemplified by phrases like
Most discussions recognize the positive findings of the research, supporting some level of agreement.
Participants display moderate interest, engaging with details like weight loss and pain reduction effects.
There is active engagement, referencing specifics such as WOMAC scores, study details, and implications for treatment.
The discussions hint at meaningful clinical impact, especially in managing obesity and osteoarthritis with new intervention insights.
Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patients with obesity and osteoarthritis with moderate to severe pain. #semaglutide https://t.co/Df4wCIcR6b https://t.co/QgY6jkMy3D
@ArmandDoma The paper says Osteoarthritis
Original Article: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis (STEP 9) https://t.co/tVDjfIDhBT Editorial: Glucagon-Like Peptide-1 Receptor Agonists and Osteoarthritis https://t.co/jKQcr4iJoo #MedTwitter https://t.co/Kwo770HLaX
Thank you for reading! Sources as follows: 1. GLP1R agonists for diabetes (https://t.co/l9DEd33w5Z), liver fibrosis (https://t.co/m7Mo9hEruE), kidney disease (https://t.co/acauBtOjVt), osteoarthritis (https://t.co/8GcpZybcHh), heart failure (https://t.co/oulxMcXNco), and
Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis. @NEJM #Obesity #medx #health https://t.co/2zccnOOYGs https://t.co/4xz1L7U10G https://t.co/fhzrUImVmu
Sources: 1. Semaglutide helps in osteoarthritis https://t.co/8GcpZyaERJ 2. GLP1 rebuilds cartilage in osteoarthritis https://t.co/zsCaofk3CB 3. Semaglutide helps in peripheral artery disease https://t.co/UWdrItPyIO 4. Direct action of GLP1 on endothelial cells
The meta-analysis found that omega-3 fatty acids significantly help reduce pain and improve joint function in osteoarthritis patients. Supplementing with n3 PUFAs appears to be a beneficial and safe option for managing…
Drs Karl and Spencer discuss the three-year tirzepatide study for prediabetes and explore semaglutide's potential in treating osteoarthritis, including its impact on weight loss, long-term side effects, and symptom…
Dr Christy discusses the study on weekly semaglutide, a glucagon-like peptide-1 receptor agonist, showing significant weight loss and pain reduction in patients with obesity and knee osteoarthritis.
You may have heard about the benefits of Wegovy as a weight loss medication but did you know that studies are also showing benefits from this medication for patients with both obesity and osteoarthritis. Emerging…
A 68-week trial studied the impact of semaglutide versus placebo on weight loss and pain relief in obese patients with knee osteoarthritis. Results show significant weight reduction and pain improvement with semaglutide.
This video discusses a 68-week trial examining how semaglutide impacts weight loss and pain relief in obese patients with knee osteoarthritis. Results show significant weight reduction and pain improvement with the…
Join Dr Hanan Taib as we explore recent breakthroughs in diabetes care, focusing on new research, treatments, and clinical strategies to improve patient outcomes and combat obesity-related conditions.
A 68-week trial evaluated semaglutide's impact on weight and pain relief in obese individuals with knee osteoarthritis. Results showed significant weight loss and pain reduction, suggesting benefits for managing…
This video reviews a 68-week study on semaglutide, a GLP-1 receptor agonist, showing significant weight loss and pain reduction in obese patients with knee osteoarthritis, highlighting its potential as a therapeutic…
A recent study explored the use of GLP-1 medications like semaglutide for knee osteoarthritis, focusing on weight loss and pain reduction in obese patients. Results showed significant improvements in both weight and…
The video discusses a 68-week randomized trial examining semaglutide's effects on weight loss and pain in obese patients with knee osteoarthritis, highlighting significant improvements compared to placebo.
This video explores the emotional impact of the film The Whale and Gabriel de Freitas's inspiring weight loss journey. It discusses obesity's complexity, recent scientific advances in treatments like semaglutide, and…
Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis | New England Journal of Medicine https://t.co/sOMdpuDPKE
RT @bella_mehta: Semaglitide did help in weight loss and decrease in pain in knee OA https://t.co/240sR5An3m #acr25 @rheumnow Question is…
RT @bella_mehta: Semaglitide did help in weight loss and decrease in pain in knee OA https://t.co/240sR5An3m #acr25 @rheumnow Question is…
RT @bella_mehta: Semaglitide did help in weight loss and decrease in pain in knee OA https://t.co/240sR5An3m #acr25 @rheumnow Question is…
Semaglitide did help in weight loss and decrease in pain in knee OA https://t.co/240sR5An3m #acr25 @rheumnow Question is that is the pain decrease is secondary to weight loss or an independent effect? https://t.co/R2v5YDP3A5
RT @AdamMeakins: No5: a very good trial that highlights how weight loss has so many positive benefits for those with knee osteoarthritis!…
@EscapeLow @hjluks @DrSeanWheeler from: https://t.co/joHZJLfXya
RT @DrSamuelBHume: Sources: 1. Semaglutide helps in osteoarthritis https://t.co/8GcpZyaERJ 2. GLP1 rebuilds cartilage in osteoarthritis…
RT @DrSamuelBHume: Sources: 1. Semaglutide helps in osteoarthritis https://t.co/8GcpZyaERJ 2. GLP1 rebuilds cartilage in osteoarthritis…
RT @DrSamuelBHume: Sources: 1. Semaglutide helps in osteoarthritis https://t.co/8GcpZyaERJ 2. GLP1 rebuilds cartilage in osteoarthritis…
RT @DrSamuelBHume: Sources: 1. Semaglutide helps in osteoarthritis https://t.co/8GcpZyaERJ 2. GLP1 rebuilds cartilage in osteoarthritis…
Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis | New England Journal of Medicine. https://t.co/6Il5v3aZxT
RT @DrSamuelBHume: Sources: 1. Semaglutide helps in osteoarthritis https://t.co/8GcpZyaERJ 2. GLP1 rebuilds cartilage in osteoarthritis…
RT @DrSamuelBHume: Sources: 1. Semaglutide helps in osteoarthritis https://t.co/8GcpZyaERJ 2. GLP1 rebuilds cartilage in osteoarthritis…
Sources: 1. Semaglutide helps in osteoarthritis https://t.co/8GcpZyaERJ 2. GLP1 rebuilds cartilage in osteoarthritis https://t.co/zsCaofk3CB 3. Semaglutide helps in peripheral artery disease https://t.co/UWdrItPyIO 4. Direct action of GLP1 on endothelial cells
@cremieuxrecueil Found it: https://t.co/AV9bBddnfv
Wegovy (semaglutida)
@IBonnx @pritanand @PoonampalPal Absolutely, check out this one: https://t.co/esVAy8OGAm
Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis | New England Journal of Medicine https://t.co/4xfL2ju0ti
https://t.co/qXbU5kx4M6 GLP1RA and Knee OA.. https://t.co/rtsFX6kIuZ
https://t.co/qXbU5kx4M6 GLP1RA and Knee OA.. https://t.co/rtsFX6kIuZ
RT @imedverse: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis. @NEJM #Obesity #medx #health https://t.co/2zccnOO…
Semaglutide in #Obesity + #Knee OA 407pt RCT, mean 56yrs, BMI 40, WOMAC pain 71, 82% women, 0-68wks: Bodywt −14% v −3% WOMAC pain −42 v −28 SF-36 phys-funct +12 v +7 Serious ad events 7% v 3% (GI) @NEJM *Funded Novo Nordisk https://t.co/Hi68AqAkrg https://t.co/Dcphd1trHE
RT @imedverse: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis. @NEJM #Obesity #medx #health https://t.co/2zccnOO…
RT @imedverse: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis. @NEJM #Obesity #medx #health https://t.co/2zccnOO…
RT @imedverse: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis. @NEJM #Obesity #medx #health https://t.co/2zccnOO…
RT @imedverse: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis. @NEJM #Obesity #medx #health https://t.co/2zccnOO…
RT @imedverse: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis. @NEJM #Obesity #medx #health https://t.co/2zccnOO…
RT @imedverse: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis. @NEJM #Obesity #medx #health https://t.co/2zccnOO…
RT @imedverse: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis. @NEJM #Obesity #medx #health https://t.co/2zccnOO…
RT @imedverse: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis. @NEJM #Obesity #medx #health https://t.co/2zccnOO…
RT @imedverse: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis. @NEJM #Obesity #medx #health https://t.co/2zccnOO…
RT @imedverse: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis. @NEJM #Obesity #medx #health https://t.co/2zccnOO…
RT @imedverse: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis. @NEJM #Obesity #medx #health https://t.co/2zccnOO…
RT @imedverse: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis. @NEJM #Obesity #medx #health https://t.co/2zccnOO…
RT @imedverse: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis. @NEJM #Obesity #medx #health https://t.co/2zccnOO…
Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis. @NEJM #Obesity #medx #health https://t.co/2zccnOOYGs https://t.co/4xz1L7U10G https://t.co/fhzrUImVmu
Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis #NEJM www.nejm.org/doi/abs/10.1...
RT @NatureAging: The paper in @NEJM https://t.co/n8sEFS40CD
RT @NatureAging: The paper in @NEJM https://t.co/n8sEFS40CD
The paper in @NEJM https://t.co/n8sEFS40CD
RT @scottisaacsmd: Semaglutide reduced pain and improved physical function in patients with obesity and osteoarthritis. #semaglutide https:…
Full text links Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis New England Journal of Medicine https://t.co/Guq1PXn7pX https://t.co/ruwc8Ap2sp
Acceso
C-COMP journal club: Jan 13 at 9 am CST Dr. Henning Bliddal from Copenhagen University will be discussing "Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis," recently featured in the New England Journal of Medicine. Please contact us for a link
Semaglutida una vez a la semana en personas con obesidad y artrosis de rodillas https://t.co/BdmQHY7J6N PMID 39476339
RT @AdamMeakins: No5: a very good trial that highlights how weight loss has so many positive benefits for those with knee osteoarthritis!…
RT @bellkneesurgeon: https://t.co/XiislKSlC6
Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis https://t.co/pM8rToavLN
RT @AdamMeakins: No5: a very good trial that highlights how weight loss has so many positive benefits for those with knee osteoarthritis!…
https://t.co/XiislKSlC6
RT @DerekGriffin86: 3. Semaglutide for knee OA This placebo controlled trial showed a significant pain reduction (vs placebo) with pharmac…
RT @DerekGriffin86: 3. Semaglutide for knee OA This placebo controlled trial showed a significant pain reduction (vs placebo) with pharmac…
RT @DerekGriffin86: 3. Semaglutide for knee OA This placebo controlled trial showed a significant pain reduction (vs placebo) with pharmac…
No5: a very good trial that highlights how weight loss has so many positive benefits for those with knee osteoarthritis! And I would bet the effects would be similar in all joint osteoarthritis… including upper limb OA https://t.co/XsGLzGRwr3
3. Semaglutide for knee OA This placebo controlled trial showed a significant pain reduction (vs placebo) with pharmacological intervention for weight loss. https://t.co/vPmqc98oyw
Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis | New England Journal of Medicine https://t.co/bE3fmvEx5F OBESIDADE ←→ ARTITE DE JOELHO Um estudo recente publicado no New England Journal of Medicine avaliou o uso de Semaglutida, um medicamento
RT @centerofhip: Hey #orthotwitter #orthox Any one prescribing semaglutide in knee oa with high bmi? This new study (funded by Novo Nor…
RT @SamuelBHume: Thank you for reading! Sources as follows: 1. GLP1R agonists for diabetes (https://t.co/l9DEd33w5Z), liver fibrosis (ht…
RT @SamuelBHume: Thank you for reading! Sources as follows: 1. GLP1R agonists for diabetes (https://t.co/l9DEd33w5Z), liver fibrosis (ht…
RT @SamuelBHume: Thank you for reading! Sources as follows: 1. GLP1R agonists for diabetes (https://t.co/l9DEd33w5Z), liver fibrosis (ht…
RT @SamuelBHume: Thank you for reading! Sources as follows: 1. GLP1R agonists for diabetes (https://t.co/l9DEd33w5Z), liver fibrosis (ht…
RT @SamuelBHume: Thank you for reading! Sources as follows: 1. GLP1R agonists for diabetes (https://t.co/l9DEd33w5Z), liver fibrosis (ht…
RT @SamuelBHume: Thank you for reading! Sources as follows: 1. GLP1R agonists for diabetes (https://t.co/l9DEd33w5Z), liver fibrosis (ht…
RT @SamuelBHume: Thank you for reading! Sources as follows: 1. GLP1R agonists for diabetes (https://t.co/l9DEd33w5Z), liver fibrosis (ht…
RT @SamuelBHume: Thank you for reading! Sources as follows: 1. GLP1R agonists for diabetes (https://t.co/l9DEd33w5Z), liver fibrosis (ht…
RT @SamuelBHume: Thank you for reading! Sources as follows: 1. GLP1R agonists for diabetes (https://t.co/l9DEd33w5Z), liver fibrosis (ht…
Thank you for reading! Sources as follows: 1. GLP1R agonists for diabetes (https://t.co/l9DEd33w5Z), liver fibrosis (https://t.co/m7Mo9hEruE), kidney disease (https://t.co/acauBtOjVt), osteoarthritis (https://t.co/8GcpZybcHh), heart failure (https://t.co/oulxMcXNco), and
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
RT @redGDPS:
RT @redGDPS:
RT @redGDPS:
RT @redGDPS:
RT @redGDPS:
RT @redGDPS:
RT @scottisaacsmd: Semaglutide reduced pain and improved physical function in patients with obesity and osteoarthritis. #semaglutide https:…
RT @scottisaacsmd: Semaglutide reduced pain and improved physical function in patients with obesity and osteoarthritis. #semaglutide https:…
RT @scottisaacsmd: Semaglutide reduced pain and improved physical function in patients with obesity and osteoarthritis. #semaglutide https:…
RT @scottisaacsmd: Semaglutide reduced pain and improved physical function in patients with obesity and osteoarthritis. #semaglutide https:…
RT @scottisaacsmd: Semaglutide reduced pain and improved physical function in patients with obesity and osteoarthritis. #semaglutide https:…
RT @scottisaacsmd: Semaglutide reduced pain and improved physical function in patients with obesity and osteoarthritis. #semaglutide https:…
RT @scottisaacsmd: Semaglutide reduced pain and improved physical function in patients with obesity and osteoarthritis. #semaglutide https:…
RT @scottisaacsmd: Semaglutide reduced pain and improved physical function in patients with obesity and osteoarthritis. #semaglutide https:…
RT @scottisaacsmd: Semaglutide reduced pain and improved physical function in patients with obesity and osteoarthritis. #semaglutide https:…
RT @scottisaacsmd: Semaglutide reduced pain and improved physical function in patients with obesity and osteoarthritis. #semaglutide https:…
#Semaglutide es todo un #blockbuster https://t.co/3hxlm3kAIu https://t.co/qhMZUMx09S
RT @scottisaacsmd: Semaglutide reduced pain and improved physical function in patients with obesity and osteoarthritis. #semaglutide https:…
RT @scottisaacsmd: Semaglutide reduced pain and improved physical function in patients with obesity and osteoarthritis. #semaglutide https:…
RT @scottisaacsmd: Semaglutide reduced pain and improved physical function in patients with obesity and osteoarthritis. #semaglutide https:…
RT @scottisaacsmd: Semaglutide reduced pain and improved physical function in patients with obesity and osteoarthritis. #semaglutide https:…
RT @scottisaacsmd: Semaglutide reduced pain and improved physical function in patients with obesity and osteoarthritis. #semaglutide https:…
RT @scottisaacsmd: Semaglutide reduced pain and improved physical function in patients with obesity and osteoarthritis. #semaglutide https:…
RT @scottisaacsmd: Semaglutide reduced pain and improved physical function in patients with obesity and osteoarthritis. #semaglutide https:…
RT @scottisaacsmd: Semaglutide reduced pain and improved physical function in patients with obesity and osteoarthritis. #semaglutide https:…
RT @scottisaacsmd: Semaglutide reduced pain and improved physical function in patients with obesity and osteoarthritis. #semaglutide https:…
RT @scottisaacsmd: Semaglutide reduced pain and improved physical function in patients with obesity and osteoarthritis. #semaglutide https:…
RT @scottisaacsmd: Semaglutide reduced pain and improved physical function in patients with obesity and osteoarthritis. #semaglutide https:…
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
RT @scottisaacsmd: Semaglutide reduced pain and improved physical function in patients with obesity and osteoarthritis. #semaglutide https:…
RT @scottisaacsmd: Semaglutide reduced pain and improved physical function in patients with obesity and osteoarthritis. #semaglutide https:…
RT @scottisaacsmd: Semaglutide reduced pain and improved physical function in patients with obesity and osteoarthritis. #semaglutide https:…
RT @scottisaacsmd: Semaglutide reduced pain and improved physical function in patients with obesity and osteoarthritis. #semaglutide https:…
RT @scottisaacsmd: Semaglutide reduced pain and improved physical function in patients with obesity and osteoarthritis. #semaglutide https:…
RT @scottisaacsmd: Semaglutide reduced pain and improved physical function in patients with obesity and osteoarthritis. #semaglutide https:…
RT @scottisaacsmd: Semaglutide reduced pain and improved physical function in patients with obesity and osteoarthritis. #semaglutide https:…
RT @scottisaacsmd: Semaglutide reduced pain and improved physical function in patients with obesity and osteoarthritis. #semaglutide https:…
RT @scottisaacsmd: Semaglutide reduced pain and improved physical function in patients with obesity and osteoarthritis. #semaglutide https:…
RT @scottisaacsmd: Semaglutide reduced pain and improved physical function in patients with obesity and osteoarthritis. #semaglutide https:…
RT @scottisaacsmd: Semaglutide reduced pain and improved physical function in patients with obesity and osteoarthritis. #semaglutide https:…
RT @scottisaacsmd: Semaglutide reduced pain and improved physical function in patients with obesity and osteoarthritis. #semaglutide https:…
RT @scottisaacsmd: Semaglutide reduced pain and improved physical function in patients with obesity and osteoarthritis. #semaglutide https:…
RT @scottisaacsmd: Semaglutide reduced pain and improved physical function in patients with obesity and osteoarthritis. #semaglutide https:…
RT @scottisaacsmd: Semaglutide reduced pain and improved physical function in patients with obesity and osteoarthritis. #semaglutide https:…
¿Es ozempic (semaglutida) la cura para el dolor de rodillas? #Ozempic #semaglutida #FelizJuevesATodos https://t.co/20ZtcggLsO https://t.co/jmEwxGrN5w
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
RT @Nurullah_Akkoc: Randomize kontrollü bir çalışmada Haftalık semaglutid enjeksiyonu, obezite ve diz osteoartriti olan hastalarda kilo kay…
Randomize kontrollü bir çalışmada Haftalık semaglutid enjeksiyonu, obezite ve diz osteoartriti olan hastalarda kilo kaybını yanısıra diz ağrısında da belirgin azalma sağladı| New England Journal of Medicine https://t.co/VRVTP1Vv3v
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
"Referencias
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis https://t.co/sswOZBne1P
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
RT @scottisaacsmd: Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patient…
Semaglutide treatment is associated with significant weight and pain reduction and improved physical function in patients with obesity and osteoarthritis with moderate to severe pain. #semaglutide https://t.co/Df4wCIcR6b https://t.co/QgY6jkMy3D
Among participants with obesity and knee osteoarthritis with moderate-to-severe pain, treatment with once-weekly injectable semaglutide resulted in significantly greater ↓ in body weight and pain than placebo. H Bliddal et al. NEJM 30 Oct 2024 https://t.co/RImp2YGDVb https://t.co/s6lyjx7bOO
¿Puede ser la nueva cura para el dolor de rodillas? #ozempic #21denoviembre #FelizJueves #dolorderodillas https://t.co/yXEJHttHGP… https://t.co/HZhBHZG4ar
11/19/24- In today’s briefing we review Ozempic Updates; COVID, H5N1, Flu, RSV updates Watch now: https://t.co/qrOsKLqg1C… #RootsEmpowers #CommunityHealth #BayArea #PublicHealth #Oakland #COVID19 #CDC #H5N1 #SARSCoV2 #Wastewater #RSV #GLP1 #Ozempic #Wegovy #Influenza https://t.co/bB0kYvuMyw
Multisociety clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period: https://t.co/wHdvAorGJU Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis: https://t.co/0TSfpP9IqD
11/19/24- In today’s briefing we review Ozempic Updates; COVID, H5N1, Flu, RSV updates Watch now: https://t.co/nUTF3K1fTS #RootsEmpowers #CommunityHealth #BayArea #PublicHealth #Oakland #COVID19 #CDC #H5N1 #SARSCoV2 #Wastewater #RSV #GLP1 #Ozempic #Wegovy #Influenza
Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis | New England Journal of Medicine https://t.co/9rSuHVN9QS
Referencia:DOI: 10.1056/NEJMoa2403664 Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis | New England Journal of Medicine #laboratorioOaxaca #osteoartritis #laboratorioDrEduardoPerezOrtega https://t.co/eLaUaHg3xA
https://t.co/zuvZZoZ763 The study, Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis, explores the impact of weekly semaglutide injections. It focuses on weight loss and pain relief for people with obesity and knee osteoarthritis (OA).
RT @HinmanRana: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis | New England Journal of Medicine https://t.co/gYwu…
RT @NutrioSci: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis @NEJM Read more https://t.co/mL8eeC2PF7
Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis @NEJM Read more https://t.co/mL8eeC2PF7 https://t.co/fSxu8exiJQ
Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis | New England Journal of Medicine https://t.co/PBkH6fMCkh 肥満による変形性関節症の人にセマグルチドをつかったら良かったよって結果。こういう使い方がベストですよね。
RT @SABOURETCardio: Once-Weekly #Semaglutide in Persons with #Obesity and Knee Osteoarthritis | New England Journal of Medicine https://t.c…
予想に易い試験と結果ではありますが、NEJMとはすごいですね。SGLT2でやってみたい研究がたくさんあるんですが。。 Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis | New England Journal of Medicine https://t.co/EaSjS9tehw
RT @SABOURETCardio: Once-Weekly #Semaglutide in Persons with #Obesity and Knee Osteoarthritis | New England Journal of Medicine https://t.c…
RT @SABOURETCardio: Once-Weekly #Semaglutide in Persons with #Obesity and Knee Osteoarthritis | New England Journal of Medicine https://t.c…
RT @SABOURETCardio: Once-Weekly #Semaglutide in Persons with #Obesity and Knee Osteoarthritis | New England Journal of Medicine https://t.c…
RT @NEJM: Original Article: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis (STEP 9) https://t.co/tVDjfIDhBT Edit…
Once-Weekly #Semaglutide in Persons with #Obesity and Knee Osteoarthritis | New England Journal of Medicine https://t.co/LqrLTeGMGS
RT @NEJM: Original Article: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis (STEP 9) https://t.co/tVDjfIDhBT Edit…
膝の痛みには減量が有効だけど、ここまで効果が出るのはすごいことだ Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis | New England Journal of Medicine https://t.co/SfnF5zY4XO
RT @NEJM: Original Article: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis (STEP 9) https://t.co/tVDjfIDhBT Edit…
RT @NEJM: Original Article: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis (STEP 9) https://t.co/tVDjfIDhBT Edit…
RT @NEJM: Original Article: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis (STEP 9) https://t.co/tVDjfIDhBT Edit…
RT @NEJM: Original Article: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis (STEP 9) https://t.co/tVDjfIDhBT Edit…
RT @NEJM: Original Article: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis (STEP 9) https://t.co/tVDjfIDhBT Edit…
RT @NEJM: Original Article: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis (STEP 9) https://t.co/tVDjfIDhBT Edit…
RT @NEJM: Original Article: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis (STEP 9) https://t.co/tVDjfIDhBT Edit…
RT @NEJM: Original Article: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis (STEP 9) https://t.co/tVDjfIDhBT Edit…
RT @NEJM: Original Article: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis (STEP 9) https://t.co/tVDjfIDhBT Edit…
RT @NEJM: Original Article: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis (STEP 9) https://t.co/tVDjfIDhBT Edit…
RT @NEJM: Original Article: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis (STEP 9) https://t.co/tVDjfIDhBT Edit…
RT @NEJM: Original Article: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis (STEP 9) https://t.co/tVDjfIDhBT Edit…
RT @CarreteroJuani: personas con #obesidad y #artrosis semaglutide 2.4 ⬇️ peso ⏬índice WOMAC (dolor , limitación funcional, rigidez) ⬇️ c…
RT @NEJM: Original Article: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis (STEP 9) https://t.co/tVDjfIDhBT Edit…
RT @NEJM: Original Article: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis (STEP 9) https://t.co/tVDjfIDhBT Edit…
RT @NEJM: Original Article: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis (STEP 9) https://t.co/tVDjfIDhBT Edit…
Journal Club SID Osteoartrite del ginocchio negli obesi: un altro target dei GLP1-ra - A cura di Gian Pio Sorice https://t.co/Hm3sx3ALhM
RT @NEJM: Original Article: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis (STEP 9) https://t.co/tVDjfIDhBT Edit…
RT @NEJM: Original Article: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis (STEP 9) https://t.co/tVDjfIDhBT Edit…
RT @NEJM: Original Article: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis (STEP 9) https://t.co/tVDjfIDhBT Edit…
RT @NEJM: Original Article: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis (STEP 9) https://t.co/tVDjfIDhBT Edit…
RT @NEJM: Original Article: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis (STEP 9) https://t.co/tVDjfIDhBT Edit…
RT @NEJM: Original Article: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis (STEP 9) https://t.co/tVDjfIDhBT Edit…
RT @NEJM: Original Article: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis (STEP 9) https://t.co/tVDjfIDhBT Edit…
RT @NEJM: Original Article: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis (STEP 9) https://t.co/tVDjfIDhBT Edit…
RT @NEJM: Original Article: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis (STEP 9) https://t.co/tVDjfIDhBT Edit…
RT @NEJM: Original Article: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis (STEP 9) https://t.co/tVDjfIDhBT Edit…
RT @NEJM: Original Article: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis (STEP 9) https://t.co/tVDjfIDhBT Edit…
RT @NEJM: Original Article: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis (STEP 9) https://t.co/tVDjfIDhBT Edit…
RT @NEJM: Original Article: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis (STEP 9) https://t.co/tVDjfIDhBT Edit…
Original Article: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis (STEP 9) https://t.co/tVDjfIDhBT Editorial: Glucagon-Like Peptide-1 Receptor Agonists and Osteoarthritis https://t.co/jKQcr4iJoo #MedTwitter https://t.co/Kwo770HLaX
RT @natalie_bellini: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis | New England Journal of Medicine This is impr…
Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis | New England Journal of Medicine https://t.co/0b5lQHEQ3e
RT @Retlouping: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis https://t.co/hLV4Rux6Eo “once-weekly injectable se…
RT @firasd: @ArmandDoma The paper says Osteoarthritis
Featured Research: Once-Weekly #Semaglutide in Persons with Obesity and Knee #Osteoarthritis https://t.co/k6RanL3n70
RT @firasd: @ArmandDoma The paper says Osteoarthritis
The mean change in the WOMAC pain score at week 68 was −41.7 points with semaglutide and −27.5 points with placebo (P<0.001). Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis | New England Journal of Medicine https://t.co/nwbvLQ2OFn
Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis | New England Journal of Medicine https://t.co/kBN3IgaoZG
Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis | New England Journal of Medicine https://t.co/w77egKUOwN
Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis https://t.co/BsNMaBrYHt
@vrcvdivn The effect is apparently in obese people with arthritis (i.e. their joint inflammation was probably due to dysmetabolism-related inflammation) so it's not exactly a miracle cure yet https://t.co/FdYJvW7cqy
RT @firasd: @ArmandDoma The paper says Osteoarthritis
RT @firasd: @ArmandDoma The paper says Osteoarthritis
Once-Weekly #Semaglutide in Persons with Obesity and #Knee Osteoarthritis resulted in significantly greater reductions in body weight and pain related to knee osteoarthritis than placebo. https://t.co/TEyQUOg0WU
Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis | New England Journal of Medicine https://t.co/ucsDnFcdVR
【RCT】肥満で中等度以上の疼痛がある中等度の変形性膝関節症患者へのセマグルチドの投与は、プラセボの投与と比較して、体重を減少させ、WOMAC疼痛スコアを改善させた。 #ペ読 https://t.co/dS6bNpQiiF
@ArmandDoma The paper says Osteoarthritis
#MedSky #EpiSky
As always, keeping the chain of knowledge intact is important. Post links. The study that this article is touting shows the majority of the decrease in pain being linked to *any intervention at all* (2/3rds happens in placebo group, pictured). Link: https://t.co/JMHLlgqZQW https://t.co/lkfIMDl0V2 https://t.co/ZjE7MppyaA
Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis https://t.co/YcgS8NDPN0
RT @Retlouping: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis https://t.co/hLV4Rux6Eo “once-weekly injectable se…
Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis | New England Journal of Medicine https://t.co/32FbedEkw9
RT @Retlouping: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis https://t.co/hLV4Rux6Eo “once-weekly injectable se…
RT @CarreteroJuani: personas con #obesidad y #artrosis semaglutide 2.4 ⬇️ peso ⏬índice WOMAC (dolor , limitación funcional, rigidez) ⬇️ c…
RT @CarreteroJuani: personas con #obesidad y #artrosis semaglutide 2.4 ⬇️ peso ⏬índice WOMAC (dolor , limitación funcional, rigidez) ⬇️ c…
RT @CarreteroJuani: personas con #obesidad y #artrosis semaglutide 2.4 ⬇️ peso ⏬índice WOMAC (dolor , limitación funcional, rigidez) ⬇️ c…
RT @CarreteroJuani: personas con #obesidad y #artrosis semaglutide 2.4 ⬇️ peso ⏬índice WOMAC (dolor , limitación funcional, rigidez) ⬇️ c…
Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis | New England Journal of Medicine https://t.co/CzaTzrOo6E
RT @agingdoc1: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis "Among participants with obesity and knee osteoarth…
RT @CarreteroJuani: personas con #obesidad y #artrosis semaglutide 2.4 ⬇️ peso ⏬índice WOMAC (dolor , limitación funcional, rigidez) ⬇️ c…
RT @agingdoc1: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis "Among participants with obesity and knee osteoarth…
RT @giovanni_ef: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis | New England Journal of Medicine https://t.co/Jfu…
Once-Weekly Semaglutide in Persons Obesity and Knee Osteoarthritis | New England Journal of Medicine https://t.co/N1EwOxHvuw
RT @CarreteroJuani: personas con #obesidad y #artrosis semaglutide 2.4 ⬇️ peso ⏬índice WOMAC (dolor , limitación funcional, rigidez) ⬇️ c…
RT @CarreteroJuani: personas con #obesidad y #artrosis semaglutide 2.4 ⬇️ peso ⏬índice WOMAC (dolor , limitación funcional, rigidez) ⬇️ c…
RT @agingdoc1: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis "Among participants with obesity and knee osteoarth…
RT @CarreteroJuani: personas con #obesidad y #artrosis semaglutide 2.4 ⬇️ peso ⏬índice WOMAC (dolor , limitación funcional, rigidez) ⬇️ c…
RT @CarreteroJuani: personas con #obesidad y #artrosis semaglutide 2.4 ⬇️ peso ⏬índice WOMAC (dolor , limitación funcional, rigidez) ⬇️ c…
The paper in "NEJM" the above "Nature" article is based upon, & links to: “Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis” 2/2 https://t.co/7wwSeuCXKA
Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis https://t.co/Rcu9sMAkqK
RT @giovanni_ef: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis | New England Journal of Medicine https://t.co/Jfu…
RT @KelseyHCollins: @UTDPainLab Link to paper for those interested: https://t.co/ptBpjd5NHF
RT @giovanni_ef: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis | New England Journal of Medicine https://t.co/Jfu…
RT @giovanni_ef: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis | New England Journal of Medicine https://t.co/Jfu…
RT @giovanni_ef: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis | New England Journal of Medicine https://t.co/Jfu…
RT @giovanni_ef: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis | New England Journal of Medicine https://t.co/Jfu…
RT @giovanni_ef: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis | New England Journal of Medicine https://t.co/Jfu…
@UTDPainLab Link to paper for those interested: https://t.co/ptBpjd5NHF
وقد وجدنا انخفاض جيد في الوزن بمتوسط 14% تقريبا مع تحسن كبير ومعتبر احصائيا في معيار ألام الركبة عند المشاركين في الدراسة كما وجدنا تحسنا كبيرا و معتبر إحصائيا في معيار جودة الحياة و الوظائف المهنيه، رابط الدراسة: https://t.co/cO4BCdrXhz
RT @giovanni_ef: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis | New England Journal of Medicine https://t.co/Jfu…
肥満と変形性膝関節症の患者に対して週1回のセマグルチドは体重と膝の痛みを減らした。STEP9trial. N Engl J Med. 2024; 391: 1573. PMID: 39476339. https://t.co/e6olR74Vnz
RT @giovanni_ef: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis | New England Journal of Medicine https://t.co/Jfu…
RT @giovanni_ef: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis | New England Journal of Medicine https://t.co/Jfu…
RT @giovanni_ef: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis | New England Journal of Medicine https://t.co/Jfu…
RT @giovanni_ef: Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis | New England Journal of Medicine https://t.co/Jfu…
Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis | New England Journal of Medicine https://t.co/JfuZ7SPvgH
PK
DR
DM
DC
BM
D
FM
R